B. Charaf et al., MHC-I NONRESTRICTED CYTOTOXIC ACTIVITY IN MACACA-SYLVANA EXPERIMENTALLY INOCULATED WITH HIV-2 AND SIV MAC, Thymus, 22(1), 1993, pp. 1-12
The anti-retrovirus cell-mediated immunity was repeatedly investigated
in seven monkeys (Macaca sylvana). Four of these animals were injecte
d with cell-free supernatants containing human immunodeficiency viruse
s: two monkeys received HIV1 Bru (2.5 x 10(6) cpm), two received HIV2
Rod (1.5 x 10(6) cpm). Two additional animals were injected with a cel
l-free supernatant containing simian immunodeficiency virus SIV/mac 25
1 (1.5 x 10(6) cpm) and the last animal served as control. The four ma
caques infected with HIV2 Rod and SIV/mac 251 seroconverted. Freshly i
solated and non stimulated peripheral blood mononuclear cells from the
se infected macaques and from the uninfected control were repeatedly a
ssessed for cytolytic activity. Target cells consisted of heterologous
human cell lines expressing HIV1 Bru, HIV2 Rod or SIV/mac proteins. A
significant cytotoxic activity, non-restricted at the major histocomp
atibility complex class I (MHC-I), was demonstrated in one HIV2 Rod-in
fected animal (F8) and in one SIV/mac 251-infected animal (M1). This l
ast animal showed progressively diminishing cytolytic activity that wa
s correlated with a pronounced decrease in CD4+ lymphocytes. An AIDS-l
ike disease developed in MI, with presence of lymphadenopathy, weight
loss, diarrhea and opportunistic infections. Cytotoxic activity was ac
tive against SIV and HIV2-infected target cells in an MHC-unrestricted
manner, it was specific to virus-infected cells and there was cross-r
eactivity between HIV2 and SIV. Cytotoxic effectors appeared to be mai
nly CD8+ cells. This model may prove to be very useful in evaluating t
he capacity of candidate AIDS vaccines to elicit effective cell-mediat
ed immune responses.